ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 771 filers reported holding ASTRAZENECA PLC in Q2 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $539,589 | +12.6% | 6,919 | -2.2% | 0.02% | +111.1% |
| Q1 2024 | $479,272 | -5.5% | 7,074 | -7.2% | 0.01% | -47.1% |
| Q4 2023 | $507,263 | -6.2% | 7,623 | -4.5% | 0.02% | -19.0% |
| Q3 2023 | $540,773 | -9.1% | 7,985 | -3.9% | 0.02% | -4.5% |
| Q2 2023 | $594,735 | +5.8% | 8,310 | +2.6% | 0.02% | 0.0% |
| Q1 2023 | $562,053 | +100807.2% | 8,098 | -1.5% | 0.02% | -29.0% |
| Q4 2022 | $557 | -99.9% | 8,221 | +0.6% | 0.03% | +14.8% |
| Q3 2022 | $448,000 | -14.0% | 8,173 | +3.6% | 0.03% | +28.6% |
| Q2 2022 | $521,000 | -23.2% | 7,888 | -22.8% | 0.02% | +16.7% |
| Q1 2022 | $678,000 | -6.6% | 10,219 | -18.0% | 0.02% | +12.5% |
| Q4 2021 | $726,000 | +23.5% | 12,468 | +27.3% | 0.02% | 0.0% |
| Q3 2021 | $588,000 | +1.2% | 9,793 | +0.9% | 0.02% | 0.0% |
| Q2 2021 | $581,000 | +11.1% | 9,705 | -30.6% | 0.02% | +14.3% |
| Q1 2021 | $523,000 | – | 13,985 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
| Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
| Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
| ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
| Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
| Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
| Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
| Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
| Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |